ACM Research (ACMR) officer exercises options, sells 18,750 shares under 10b5-1 plan
Rhea-AI Filing Summary
ACM Research, Inc. insider activity: Officer Cheav Sotheara reported exercising stock options for 18,750 shares of Class A Common Stock at an exercise price of $13.89 per share and selling 18,750 shares in open-market transactions on June 4–5, 2026.
The sales were executed at reported prices generally in the low-to-mid $80s per share across multiple trades and were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2026. Following these transactions, Sotheara directly holds 100,002 shares of ACM Research Class A Common Stock.
Positive
- None.
Negative
- None.
Insights
Routine option exercise and 10b5-1 sales with sizable stake retained.
Officer Cheav Sotheara exercised options to acquire 18,750 ACM Research Class A shares at an exercise price of $13.89 and sold 18,750 shares in open-market trades at prices reported in the low-to-mid $80s per share.
The filing shows 7 sale transactions and 2 derivative exercises, with post-transaction direct holdings of 100,002 shares. A footnote states the sales were made under a Rule 10b5-1 trading plan adopted on March 5, 2026, suggesting these were pre-planned rather than opportunistic trades.
Because the sale volume is modest relative to the remaining position and the activity is tied to option exercises and a pre-arranged plan, the transactions appear routine from a compensation and liquidity standpoint rather than a strong directional signal about ACM Research’s prospects.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 5,399 | $0.00 | -- |
| Exercise | Class A Common Stock | 5,399 | $13.89 | $75K |
| Sale | Class A Common Stock | 2,384 | $81.73 | $195K |
| Sale | Class A Common Stock | 968 | $82.61 | $80K |
| Sale | Class A Common Stock | 400 | $84.01 | $34K |
| Sale | Class A Common Stock | 1,647 | $85.41 | $141K |
| Exercise | Stock Option | 13,351 | $0.00 | -- |
| Exercise | Class A Common Stock | 13,351 | $13.89 | $185K |
| Sale | Class A Common Stock | 1,300 | $84.08 | $109K |
| Sale | Class A Common Stock | 9,212 | $85.11 | $784K |
| Sale | Class A Common Stock | 2,839 | $85.77 | $244K |
Footnotes (1)
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.61 to $84.4, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5), (6), (7), and (8) to this Form 4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.63 to $85.6, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.7 to $86.19, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.22 to $82.07, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.38 to $82.89, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.85 to $84.5, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.27 to $85.72, inclusive. The option is fully vested and exercisable.